Total group (n = 94) | Study group (n = 18) | Control group (n = 18) | p-values* | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
n | % | value (range) | n | % | value (range) | n | % | value (range) | |||
Surgical treatment | Total | 88 | 93.6 | 17 | 94.4 | 15 | 83.3 | (0.279) | |||
Local resection | 78 | 83.0 | 14 | 77.7 | 14 | 77.7 | (0.397) | ||||
Neck dissection | 10 | 10.6 | 3 | 16.7 | 1 | 5.6 | (0.790) | ||||
Brachytherapy | Total dose (Gy) | 25.9 (10–35) | 27.0 (15–35) | 27.1 (20–30) | (0.696) | ||||||
Single dose (Gy) | 2.5 (2.5-4.5) | 2.5 (2.5-3.0) | 2.5 (2.5-2.5) | (0.791) | |||||||
Fractions | 10.2 (4–14) | 10.6 (6–14) | 10.8 (8–12) | (0.938) | |||||||
Radiation days | 6.3 (1–11) | 7.1 (4–9) | 6.6 (3–9) | (0.202) | |||||||
V100 (ml) | 50.0 (3.6-149.5) | 61.9 (22.3-149.5) | 46.4 (4.0-111.1) | (0.291) | |||||||
V150 (ml) | 19.1 (1.6-65.3) | 23.1 (7.1-55.2) | 17.0 (2.0-37.3) | (0.347) | |||||||
DNR | 0.37 (0.32-0.56) | 0.35 (0.28-0.46) | 0.40 (0.29-0.56) | (0.168) | |||||||
Adjuvant treatment | EBRT | 24 | 25.5 | 4 | 22.2 | 3 | 16.7 | (0.557) | |||
Radiation dose (Gy) | 48.7 (30–60) | 50.1 (50.0-50.4) | 35.8 (30–45) | (0.887) | |||||||
Chemotherapy (total) | 15 | 16.0 | 18 | 100 | 2 | 11.1 | (0.000) | ||||
Chemotherapy (only platinum derivatives) | 5 | 5.3 | 2 | 11.1 | - | - |